| Title | The activity of erythropoietin as the pathogenetic component of anemia in acute myeloid leukemia |
| Publication Type | Journal Article |
| Year of Publication | 2014 |
| Authors | Lanovenko, II, Berezyuk, OM |
| Abbreviated Key Title | Dopov. Nac. akad. nauk Ukr. |
| DOI | 10.15407/dopovidi2014.12.166 |
| Issue | 12 |
| Section | Medicine |
| Pagination | 166-174 |
| Date Published | 12/2014 |
| Language | Ukrainian |
| Abstract | During the investigation of the patients with acute myeloid leukemia (AML) under the conditions of intensive chemotherapy (CT), the development of anemia, the inadequacy of production, and the deficit of endogenic erythropoietin (EPO) are established. Insufficient production of EPO appeared in 80% of patients with AML before the conducting CT and in all patients after CT. A reduction in the production and the development of EPO insufficiency are accompanied by a deepening of anemia, disturbances of the metabolism of iron, and by an increase in the need for the pouring of erythrocytic mass. The pathogenetic role of the EPO insufficiency in the genesis of anemia is shown, and the expediency of erythropoietintherapy in sick AML is substantiated. |
| Keywords | acute myeloid leukemia, anemia, erythropoietin, pathogenetic component |
1. Alekseev N. A. Anemia: A Practical Guide, St. Petersburg: Gippokrat, 2004 (in Russian).
2. Guide to Hematology (Eds. Vorobiev A. I.), Moscow: Niudiamed, 2007 (in Russian).
3. Blau A. C. Stem Cells., 2007, 25, No 8: 2094. – 2097.
4. Caro J. J., Salas M., Ward A. et al. Cancer., 2001, 91, No 12: 2214–2221. https://doi.org/10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P
5. Elliott S., Pham E., Macdougall I. C. Exp. hematol. – 2008, 36, No 12: 1573–1584. https://doi.org/10.1016/j.exphem.2008.08.003
6. Fisher J. W. Exp. Biol. and Med., 2003, 228, No 1: 1–14.
7. Moncada S., Palmer R. M. J., Higgs E. A. Pharmacol. Rev., 1991, 43, No 2: 109–142.
8. Semenza G. L. Physiology, 2009, 24, No 2: 97–106. https://doi.org/10.1152/physiol.00045.2008
9. Erythropoietin (Eds. Rumyantsev A. G., Morshakova E. F., Pavlov A. D.), Moscow: Geotar-Med., 2002 (in Russian).
10. Fliser D., Haller H. Hematology, 2007, 44, No 3: 212–217.
11. Kostova G., Siljanovski N. Prilosi., 2004, 25, No 1–2: 53–66.
12. Py J. Y., Leo-Kodeli S., Fauveau L. et al. Transfus. Clin. Biol. 2009, 16, No 1: 12–20. https://doi.org/10.1016/j.tracli.2009.01.004
13. Tanno T., Miller J. L. Adv. Hematol., 2010, 21: 1–8. https://doi.org/10.1155/2010/358283
14. Bennett C. L., Luminari S., Nissenson A. R. et al. N. Engl. J. Med., 2004, 351, No 14: 1403–1408. https://doi.org/10.1056/NEJMoa040528
15. Lakin G. F. Biometrics, 3th ed., Moscow: Vyssh. shk., 1982 (in Russian).
